Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases

Details for Australian Patent Application No. 2006235489 (hide)

Owner Intradigm Corporation

Inventors Lui, Yijia; Zhou, Qin; Schiffelers, Raymond; Xie, Frank Yuefeng; Tang, Quinn Q.; Scaria, Puthupparampil V.; Woodle, Martin C.; Yang Lu, Patrick; Xu, Jun

Agent Cullen & Co

Pub. Number AU-A-2006235489

PCT Pub. Number WO2006/110813

Priority 60/670,717 12.04.05 US

Filing date 12 April 2006

Wipo publication date 19 October 2006

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

22 November 2007 PCT application entered the National Phase

  PCT publication WO2006/110813 Priority application(s): WO2006/110813

6 December 2007 Amendment Made

  The nature of the amendment is: Amend the name of the co-inventor from Lui, Yijia to Liu, Yijia

10 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006235490-Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents

2006235487-Nanoparticulate quinazoline derivative formulations